104 related articles for article (PubMed ID: 20430444)
21. Scanning electron microscopic studies of megakaryocytes and platelet formation in the dog and rat.
Handagama P; Jain NC; Kono CS; Feldman BF
Am J Vet Res; 1986 Nov; 47(11):2454-60. PubMed ID: 3789509
[TBL] [Abstract][Full Text] [Related]
22. [Megakaryocytic myelosis--cause of "idiopathic" thrombocythemia].
Burkhardt R; Kronseder A
Fortschr Med; 1977 May; 95(19):1261-6. PubMed ID: 863367
[TBL] [Abstract][Full Text] [Related]
23. Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes.
Ong L; Morison IM; Ledgerwood EC
Br J Haematol; 2017 Jan; 176(2):268-279. PubMed ID: 27861742
[TBL] [Abstract][Full Text] [Related]
24. Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms.
Malherbe JA; Fuller KA; Arshad A; Nangalia J; Romeo G; Hall SL; Meehan KS; Guo B; Howman R; Erber WN
J Clin Pathol; 2016 Feb; 69(2):155-63. PubMed ID: 26290261
[TBL] [Abstract][Full Text] [Related]
25. Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis.
Theophile K; Hussein K; Kreipe H; Bock O
Exp Hematol; 2008 Dec; 36(12):1728-38. PubMed ID: 18838203
[TBL] [Abstract][Full Text] [Related]
26. Megakaryocytic myelosis in a cat.
Michel RL; O'Handley P; Dade AW
J Am Vet Med Assoc; 1976 Jun; 168(11):1021-5. PubMed ID: 931768
[TBL] [Abstract][Full Text] [Related]
27. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
Nagao T; Yonekura S
Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
[No Abstract] [Full Text] [Related]
29. [Chronic myeloproliferative diseases].
Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
[No Abstract] [Full Text] [Related]
30. Myelofibrosis: molecular and cell biological aspects.
Kreipe H; Büsche G; Bock O; Hussein K
Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S21. PubMed ID: 23259436
[TBL] [Abstract][Full Text] [Related]
31. Ultrastructural analysis of acute immune thrombocytopenia in mice: dissociation between alterations in megakaryocytes and platelets.
Stenberg PE; Levin J
J Cell Physiol; 1989 Oct; 141(1):160-9. PubMed ID: 2777899
[TBL] [Abstract][Full Text] [Related]
32. Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm.
Hussein K; Dralle W; Theophile K; Kreipe H; Bock O
Ann Hematol; 2009 Apr; 88(4):325-32. PubMed ID: 18773208
[TBL] [Abstract][Full Text] [Related]
33. Histomorphometric study of megakaryocytes in bone marrow in selected myeloproliferative and lymphoproliferative diseases.
Lemancewicz D; Dziecioł J; Kłoczko J; Litwiejko-Pietryńczak E; Bogusłowicz W
Folia Morphol (Warsz); 2003 Feb; 62(1):51-6. PubMed ID: 12769178
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
Matolcsy A; Kónya T; Wéber E
Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
[TBL] [Abstract][Full Text] [Related]
35. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction.
Thiele J; Titius BR; Kvasnicka HM; Rechmeier W; Fischer R
Anal Cell Pathol; 1994 Jul; 7(1):63-75. PubMed ID: 7981137
[TBL] [Abstract][Full Text] [Related]
36. Inability of immunomorphometric assessment of angiogenesis to distinguish primary versus secondary myelofibrosis.
Sharma P; Pati HP; Mishra PC; Dinda AK; Gupta R; Sharma A; Jacob TG
Anal Quant Cytol Histol; 2011 Aug; 33(4):236-44. PubMed ID: 21980629
[TBL] [Abstract][Full Text] [Related]
37. Ultrastructure of bone marrow tissue in so-called primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia). I. Abnormalities of megakaryopoiesis and thrombocytes.
Thiele J; Kuemmel T; Sander C; Fischer R
J Submicrosc Cytol Pathol; 1991 Jan; 23(1):93-107. PubMed ID: 2036630
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
[TBL] [Abstract][Full Text] [Related]
39. Chronic megakaryocytic-granulocytic myelosis--an electron microscopic study. I. Megakaryocytes and thrombocytes.
Thiele J; Ballard AC; Georgii A; Vykoupil KF
Virchows Arch A Pathol Anat Histol; 1977 Apr; 373(3):191-211. PubMed ID: 140504
[TBL] [Abstract][Full Text] [Related]
40. Localization of megakaryocytes in the bone marrow.
Tavassoli M; Aoki M
Blood Cells; 1989; 15(1):3-14. PubMed ID: 2649185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
